Search

Your search keyword '"Fogel, Evan L."' showing total 866 results
Start Over Author "Fogel, Evan L." Publication Year Range Last 50 years
866 results on '"Fogel, Evan L."'

4. Diagnosis of chronic pancreatitis using semi-quantitative MRI features of the pancreatic parenchyma: results from the multi-institutional MINIMAP study

Author

Tirkes, Temel, Yadav, Dhiraj, Conwell, Darwin L., Territo, Paul R., Zhao, Xuandong, Persohn, Scott A., Dasyam, Anil K., Shah, Zarine K., Venkatesh, Sudhakar K., Takahashi, Naoki, Wachsman, Ashley, Li, Liang, Li, Yan, Pandol, Stephen J., Park, Walter G., Vege, Santhi Swaroop, Hart, Phil A., Topazian, Mark, Andersen, Dana K., and Fogel, Evan L.

Published
2023
Full Text
View/download PDF

5. Rationale and Design for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study

Author

Hart, Phil A, Papachristou, Georgios I, Park, Walter G, Dyer, Anne-Marie, Chinchilli, Vernon M, Afghani, Elham, Akshintala, Venkata S, Andersen, Dana K, Buxbaum, James L, Conwell, Darwin L, Dungan, Kathleen M, Easler, Jeffrey J, Fogel, Evan L, Greenbaum, Carla J, Kalyani, Rita R, Korc, Murray, Kozarek, Richard, Laughlin, Maren R, Lee, Peter J, Maranki, Jennifer L, Pandol, Stephen J, Phillips, Anna Evans, Serrano, Jose, Singh, Vikesh K, Speake, Cate, Tirkes, Temel, Toledo, Frederico GS, Trikudanathan, Vege, Santhi Swaroop, Wang, Ming, Yazici, Cemal, Zaheer, Atif, Forsmark, Christopher E, Bellin, Melena D, and Yadav, Dhiraj

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Prevention, Diabetes, Acute Disease, Diabetes Mellitus, Type 1, Humans, Incidence, Pancreatitis, Prospective Studies, pancreatogenic diabetes, type 3c diabetes, beta cell, insulin, autoantibody, epidemiology, AP, acute pancreatitis, CP, chronic pancreatitis, DCC, data coordinating center, DM, diabetes mellitus, DREAM, Diabetes RElated to Acute pancreatitis and its Mechanisms, FSIGTT, frequently sampled intravenous glucose tolerance testing, OGTT, oral glucose tolerance testing, MMTT, mixed meal tolerance testing, T1DAPC, Type 1 Diabetes in Acute Pancreatitis Consortium, Gastroenterology & Hepatology, Clinical sciences
Abstract

AbstractAcute pancreatitis (AP) is a disease characterized by an acute inflammatory phase followed by a convalescent phase. Diabetes mellitus (DM) was historically felt to be a transient phenomenon related to acute inflammation; however, it is increasingly recognized as an important late and chronic complication. There are several challenges that have prevented precisely determining the incidence rate of DM after AP and understanding the underlying mechanisms. The DREAM (Diabetes RElated to Acute Pancreatitis and its Mechanisms) Study is a prospective cohort study designed to address these and other knowledge gaps to provide the evidence needed to screen for, prevent, and treat DM after AP. In the following article, we summarize literature regarding the epidemiology of DM after AP and provide the rationale and an overview of the DREAM study.

Published
2022

7. Systemic Neutrophil Gelatinase-Associated Lipocalin Alterations in Chronic Pancreatitis: A Multicenter, Cross-Sectional Study

Author

Gumpper-Fedus, Kristyn, Chasser, Kaylin, Pita-Grisanti, Valentina, Torok, Molly, Pfau, Timothy, Mace, Thomas A., Cole, Rachel M., Belury, Martha A., Culp, Stacey, Hart, Phil A., Krishna, Somashekar G., Lara, Luis F., Ramsey, Mitchell L., Fisher, William, Fogel, Evan L., Forsmark, Chris E., Li, Liang, Pandol, Stephen, Park, Walter G., Serrano, Jose, Van Den Eeden, Stephen K., Vege, Santhi Swaroop, Yadav, Dhiraj, Conwell, Darwin L., and Cruz-Monserrate, Zobeida

Published
2024
Full Text
View/download PDF

8. Circulating immune signatures in chronic pancreatitis with and without preceding acute pancreatitis: A pilot study

Author

Hagn-Meincke, Rasmus, Yadav, Dhiraj, Andersen, Dana K., Vege, Santhi Swaroop, Fogel, Evan L., Serrano, Jose, Bellin, Melena D., Topazian, Mark D., Conwell, Darwin L., Li, Liang, Van Den Eeden, Stephen K., Drewes, Asbjørn M., Pandol, Stephen J., Forsmark, Chris E., Fisher, William E., Hart, Phil A., Olesen, Søren S., and Park, Walter G.

Published
2024
Full Text
View/download PDF

9. Pancreatitis pain quality changes at year 1 follow-up, but GP130 remains a biomarker for pain

Author

Saloman, Jami L, Jennings, Kristofer, Stello, Kimberly, Li, Shuang, Evans Phillips, Anna, Hall, Kristen, Fogel, Evan L., Vege, Santhi Swaroop, Andersen, Dana K., Fisher, William E., Forsmark, Christopher E., Hart, Phil A., Pandol, Stephen J., Park, Walter G., Topazian, Mark D., Van Den Eeden, Stephen K., Serrano, Jose, Conwell, Darwin L., Li, Liang, and Yadav, Dhiraj

Published
2024
Full Text
View/download PDF

10. Serum Biomarkers of Nociceptive and Neuropathic Pain in Chronic Pancreatitis

Author

Saloman, Jami L., Li, Yan, Stello, Kimberly, Li, Wenhao, Li, Shuang, Phillips, Anna Evans, Hall, Kristen, Fogel, Evan L., Vege, Santhi Swaroop, Li, Liang, Andersen, Dana K., Fisher, William E., Forsmark, Christopher E., Hart, Phil A., Pandol, Stephen J., Park, Walter G., Topazian, Mark D., Van Den Eeden, Stephen K., Serrano, Jose, Conwell, Darwin L., and Yadav, Dhiraj

Published
2023
Full Text
View/download PDF

12. Distinct Serum Immune Profiles Define the Spectrum of Acute and Chronic Pancreatitis From the Multicenter Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) Study

Author

Li, Liang, Yadav, Dhiraj, Conwell, Darwin L., Hart, Phil A., Vege, Santhi Swaroop, Fogel, Evan L., Serrano, Jose, Andersen, Dana, Bellin, Melena D., Topazian, Mark, Van Den Eeden, Stephen K., Pandol, Stephen J., Forsmark, Chris, Fisher, William E., Park, Walter G., Lee, Bomi, Jones, Elaina K., Manohar, Murli, Topazian, Mark D., Forsmark, Chris E., Husain, Sohail Z., and Habtezion, Aida

Published
2023
Full Text
View/download PDF

13. Quantitative MRI of chronic pancreatitis: results from a multi-institutional prospective study, magnetic resonance imaging as a non-invasive method for assessment of pancreatic fibrosis (MINIMAP)

Author

Tirkes, Temel, Yadav, Dhiraj, Conwell, Darwin L., Territo, Paul R., Zhao, Xuandong, Persohn, Scott A., Dasyam, Anil K., Shah, Zarine K., Venkatesh, Sudhakar K., Takahashi, Naoki, Wachsman, Ashley, Li, Liang, Li, Yan, Pandol, Stephen J., Park, Walter G., Vege, Santhi S., Hart, Phil A., Topazian, Mark, Andersen, Dana K., and Fogel, Evan L.

Published
2022
Full Text
View/download PDF

14. T1 signal intensity ratio of the pancreas as an imaging biomarker for the staging of chronic pancreatitis

Author

Tirkes, Temel, Dasyam, Anil K., Shah, Zarine K., Fogel, Evan L., Vege, Santhi Swaroop, Li, Liang, Li, Shuang, Chang, Stephanie T., Farinas, Carlos A., Grajo, Joseph R., Mawad, Kareem, Takahashi, Naoki, Venkatesh, Sudhakar K., Wachsman, Ashley, Fisher, William E., Forsmark, Christopher E., Hart, Phil A., Pandol, Stephen J., Park, Walter G., Van Den Eeden, Stephen K., Yang, Yunlong, Topazian, Mark, Andersen, Dana K., Serrano, Jose, Conwell, Darwin L., and Yadav, Dhiraj

Published
2022
Full Text
View/download PDF

17. Diagnostic and Prognostic Biomarkers of Chronic Pancreatitis: A Conceptual Framework Based on the PRoBE Design

Author

Yadav, Dhiraj, primary, Conwell, Darwin L., additional, Pandol, Stephen J., additional, Steen, Hanno, additional, Feng, Ziding, additional, Li, Liang, additional, Andersen, Dana, additional, Bellin, Melena, additional, Chari, Suresh T., additional, Cruz-Monserrate, Zobeida, additional, Fisher, William E., additional, Fogel, Evan L., additional, Forsmark, Christopher E., additional, Hart, Phil A., additional, Lesinski, Gregory B., additional, Park, Walter G., additional, Rinaudo, Jo Ann, additional, Saloman, Jami L., additional, Serrano, Jose, additional, Tirkes, Temel, additional, Topazian, Mark D., additional, van Den Eeden, Stephen, additional, Vege, Santhi Swaroop, additional, and Whitcomb, David C., additional

Published
2024
Full Text
View/download PDF

19. SpHincterotomy for Acute Recurrent Pancreatitis Randomized Trial: Rationale, Methodology, and Potential Implications.

Author

Coté, Gregory A, Durkalski-Mauldin, Valerie L, Serrano, Jose, Klintworth, Erin, Williams, April W, Cruz-Monserrate, Zobeida, Arain, Mustafa, Buxbaum, James L, Conwell, Darwin L, Fogel, Evan L, Freeman, Martin L, Gardner, Timothy B, van Geenen, Erwin, Groce, J Royce, Jonnalagadda, Sreenivasa S, Keswani, Rajesh N, Menon, Shyam, Moffatt, Dana C, Papachristou, Georgios I, Ross, Andrew, Tarnasky, Paul R, Wang, Andrew Y, Wilcox, C Mel, Hamilton, Frank, and Yadav, Dhiraj

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Clinical Trials and Supportive Activities, Prevention, Digestive Diseases, Clinical Research, Oral and gastrointestinal, Adult, Cholangiopancreatography, Endoscopic Retrograde, Cholangiopancreatography, Magnetic Resonance, Cohort Studies, Endosonography, Female, Humans, Internationality, Male, Outcome Assessment, Health Care, Pancreas, Pancreatitis, Recurrence, Risk Factors, Secondary Prevention, Sphincterotomy, Endoscopic, acute pancreatitis, acute recurrent pancreatitis, chronic pancreatitis, endoscopic retrograde cholangiopancreatography, pancreas divisum, SHARP Consortium, Gastroenterology & Hepatology, Clinical sciences
Abstract

ObjectivesIn patients with acute recurrent pancreatitis (ARP), pancreas divisum, and no other etiologic factors, endoscopic retrograde cholangiopancreatography (ERCP) with minor papilla endoscopic sphincterotomy (miES) is often performed to enlarge the minor papillary orifice, based on limited data. The aims of this study are to describe the rationale and methodology of a sham-controlled clinical trial designed to test the hypothesis that miES reduces the risk of acute pancreatitis.MethodsThe SpHincterotomy for Acute Recurrent Pancreatitis (SHARP) trial is a multicenter, international, sham-controlled, randomized trial comparing endoscopic ultrasound + ERCP with miES versus endoscopic ultrasound + sham for the management of ARP. A total of 234 consented patients having 2 or more discrete episodes of acute pancreatitis, pancreas divisum confirmed by magnetic resonance cholangiopancreatography, and no other clear etiology for acute pancreatitis will be randomized. Both cohorts will be followed for a minimum of 6 months and a maximum of 48 months.ResultsThe trial is powered to detect a 33% risk reduction of acute pancreatitis frequency.ConclusionsThe SHARP trial will determine whether ERCP with miES benefits patients with idiopathic ARP and pancreas divisum. Trial planning has informed the importance of blinded outcome assessors and long-term follow-up.

Published
2019

20. Magnetic resonance imaging as a non-invasive method for the assessment of pancreatic fibrosis (MINIMAP): a comprehensive study design from the consortium for the study of chronic pancreatitis, diabetes, and pancreatic cancer

Author

Tirkes, Temel, Yadav, Dhiraj, Conwell, Darwin L, Territo, Paul R, Zhao, Xuandong, Venkatesh, Sudhakar K, Kolipaka, Arunark, Li, Liang, Pisegna, Joseph R, Pandol, Stephen J, Park, Walter G, Topazian, Mark, Serrano, Jose, and Fogel, Evan L

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Rare Diseases, Bioengineering, Biomedical Imaging, Cancer, Clinical Research, Digestive Diseases, Pancreatic Cancer, 4.2 Evaluation of markers and technologies, 4.1 Discovery and preclinical testing of markers and technologies, Detection, screening and diagnosis, Oral and gastrointestinal, Chronic Disease, Fibrosis, Humans, Magnetic Resonance Imaging, Multicenter Studies as Topic, Pancreatitis, United States, Chronic pancreatitis, MRI, MRCP, T-1 mapping, Extracellular volume, Diffusion-weighted imaging, MR elastography, Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer, T 1 mapping, Nuclear Medicine & Medical Imaging, Clinical sciences
Abstract

Characteristic features of chronic pancreatitis (CP) may be absent on standard imaging studies. Quantitative Magnetic Resonance Imaging (MRI) techniques such as T1 mapping, extracellular volume (ECV) fraction, diffusion-weighted imaging (DWI) with apparent diffusion coefficient map (ADC), MR elastography (MRE), and T1-weighted signal intensity ratio (SIR) have shown promise for the diagnosis and grading severity of CP. However, radiologists still use the Cambridge classification which is based on traditional ductal imaging alone. There is an urgent need to develop new diagnostic criteria that incorporate both parenchymal and ductal features of CP seen by MRI/MRCP. Designed to fulfill this clinical need, we present the MINIMAP study, which was funded in September 2018 by the National Institutes of Health. This is a comprehensive quantitative MR imaging study which will be performed at multiple institutions in well-phenotyped CP patient cohorts. We hypothesize that quantitative MRI/MRCP features can serve as valuable non-invasive imaging biomarkers to detect and grade CP. We will evaluate the role of T1 relaxometry, ECV, T1-weighted gradient echo SIR, MRE, arteriovenous enhancement ratio, ADC, pancreas volume/atrophy, pancreatic fat fraction, ductal features, and pancreatic exocrine output following secretin stimulation in the assessment of CP. We will attempt to generate a multi-parametric pancreatic tissue fibrosis (PTF) scoring system. We anticipate that a quantitative scoring system may serve as a biomarker of pancreatic fibrosis; hence this imaging technique can be used in clinical practice as well as clinical trials to evaluate the efficacy of agents which may slow the progression or reverse measures of CP.

Published
2019

21. PROspective Evaluation of Chronic Pancreatitis for EpidEmiologic and Translational StuDies

Author

Yadav, Dhiraj, Park, Walter G, Fogel, Evan L, Li, Liang, Chari, Suresh T, Feng, Ziding, Fisher, William E, Forsmark, Christopher E, Jeon, Christie Y, Habtezion, Aida, Hart, Phil A, Hughes, Steven J, Othman, Mohamed O, Rinaudo, Jo Ann S, Pandol, Stephen J, Tirkes, Temel, Serrano, Jose, Srivastava, Sudhir, Van Den Eeden, Stephen K, Whitcomb, David C, Topazian, Mark, and Conwell, Darwin L

Subjects
Biomedical and Clinical Sciences, Clinical Sciences, Pancreatic Cancer, Prevention, Digestive Diseases, Rare Diseases, Cancer, Clinical Research, 2.1 Biological and endogenous factors, 4.2 Evaluation of markers and technologies, Detection, screening and diagnosis, Aetiology, Oral and gastrointestinal, Adult, Biomarkers, Blood Specimen Collection, Diabetes Mellitus, Disease Progression, Humans, Longitudinal Studies, Observational Studies as Topic, Outcome Assessment, Health Care, Pancreatic Neoplasms, Pancreatitis, Chronic, Prospective Studies, Research Design, Specimen Handling, Translational Research, Biomedical, United States, pancreas, alcohol, tobacco, genetic, biorepository, cohort, Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer, Gastroenterology & Hepatology, Clinical sciences
Abstract

Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) is the first prospective, observational cohort study of chronic pancreatitis (CP) in the United States. The primary goals of PROCEED are to define disease progression, test the predictive capability of candidate biomarkers, and develop a platform to conduct translational and mechanistic studies in CP. Using objective and consensus-driven criteria, PROCEED will enroll adults at different stages of CP-controls, suspected CP, and definite CP. In addition to collecting detailed information using structured case report forms and protocol-mandated evaluations at baseline and during follow-up, PROCEED will establish a linked biorepository of blood, urine, saliva, stool, pancreatic fluid, and pancreatic tissue. Enrollment for PROCEED began in June 2017. As of July 1, 2018, nine clinical centers of the Consortium for the Study of Chronic Pancreatitis, Diabetes, and Pancreatic Cancer are enrolling, and 350 subjects have completed baseline evaluation. In conclusion, PROCEED will provide the most accurate and reliable estimates to date on progression of CP. The established cohort and biorepository will facilitate numerous analyses, leading to new strategies for diagnosis, methods to monitor disease progression, and treatment of CP.

Published
2018

24. Safety, Tolerability, and Dose-Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis: Protocol for a Phase 1 Clinical Trial to Determine Safety and Identify Side Effects

Author

Fogel, Evan L, primary, Easler, Jeffrey J, additional, Yuan, Ying, additional, Yadav, Dhiraj, additional, Conwell, Darwin L, additional, Vege, Santhi Swaroop, additional, Han, Samuel Y, additional, Park, Walter, additional, Patrick, Vanessa, additional, and White, Fletcher A, additional

Published
2024
Full Text
View/download PDF

25. Digestive Manifestations in Patients Hospitalized With Coronavirus Disease 2019

Author

Elmunzer, B. Joseph, Spitzer, Rebecca L., Foster, Lydia D., Merchant, Ambreen A., Howard, Eric F., Patel, Vaishali A., West, Mary K., Qayed, Emad, Nustas, Rosemary, Zakaria, Ali, Piper, Marc S., Taylor, Jason R., Jaza, Lujain, Forbes, Nauzer, Chau, Millie, Lara, Luis F., Papachristou, Georgios I., Volk, Michael L., Hilson, Liam G., Zhou, Selena, Kushnir, Vladimir M., Lenyo, Alexandria M., McLeod, Caroline G., Amin, Sunil, Kuftinec, Gabriela N., Yadav, Dhiraj, Fox, Charlie, Kolb, Jennifer M., Pawa, Swati, Pawa, Rishi, Canakis, Andrew, Huang, Christopher, Jamil, Laith H., Aneese, Andrew M., Glamour, Benita K., Smith, Zachary L., Hanley, Katherine A., Wood, Jordan, Patel, Harsh K., Shah, Janak N., Agarunov, Emil, Sethi, Amrita, Fogel, Evan L., McNulty, Gail, Haseeb, Abdul, Trieu, Judy A., Dixon, Rebekah E., Yang, Jeong Yun, Mendelsohn, Robin B., Calo, Delia, Aroniadis, Olga C., LaComb, Joseph F., Scheiman, James M., Sauer, Bryan G., Dang, Duyen T., Piraka, Cyrus R., Shah, Eric D., Pohl, Heiko, Tierney, William M., Mitchell, Stephanie, Condon, Ashwinee, Lenhart, Adrienne, Dua, Kulwinder S., Kanagala, Vikram S., Kamal, Ayesha, Singh, Vikesh K., Pinto-Sanchez, Maria Ines, Hutchinson, Joy M., Kwon, Richard S., Korsnes, Sheryl J., Singh, Harminder, Solati, Zahra, Willingham, Field F., Yachimski, Patrick S., Conwell, Darwin L., Mosier, Evan, Azab, Mohamed, Patel, Anish, Buxbaum, James, Wani, Sachin, Chak, Amitabh, Hosmer, Amy E., Keswani, Rajesh N., DiMaio, Christopher J., Bronze, Michael S., Muthusamy, Raman, Canto, Marcia I., Gjeorgjievski, V. Mihajlo, Imam, Zaid, Odish, Fadi, Edhi, Ahmed I., Orosey, Molly, Tiwari, Abhinav, Patwardhan, Soumil, Brown, Nicholas G., Patel, Anish A., Ordiah, Collins O., Sloan, Ian P., Cruz, Lilian, Koza, Casey L., Okafor, Uchechi, Hollander, Thomas, Furey, Nancy, Reykhart, Olga, Zbib, Natalia H., Damianos, John A., Esteban, James, Hajidiacos, Nick, Saul, Melissa, Mays, Melanie, Anderson, Gulsum, Wood, Kelley, Mathews, Laura, Diakova, Galina, Caisse, Molly, Wakefield, Lauren, Nitchie, Haley, Waljee, Akbar K., Tang, Weijing, Zhang, Yueyang, Zhu, Ji, Deshpande, Amar R., Rockey, Don C., Alford, Teldon B., and Durkalski, Valerie

Published
2021
Full Text
View/download PDF

27. Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19

Author

Merchant, Ambreen A., Patel, Vaishali A., Willingham, Field F., Howard, Eric F., West, Mary K., Koza, Casey L., Yachimski, Patrick S., Qayed, Emad, Nustas, Rosemary, Zakaria, Ali, Piper, Marc S., Jaza, Lujain, Forbes, Nauzer, Chau, Millie, Lara, Luis F., Papachristou, Georgios I., Okafor, Uchechi, Conwell, Darwin L., Volk, Michael L., Mosier, Evan, Azab, Mohamed, Patel, Anish, Hilson, Liam G., Zhou, Selena, Buxbaum, James, Kushnir, Vladimir M., Lenyo, Alexandria M., Sloan, Ian P., Hollander, Thomas, McLeod, Caroline G., Spitzer, Rebecca L., Wakefield, Lauren, Nitchie, Haley, Ordiah, Collins O., Rockey, Don C., Alford, Teldon B., Amin, Sunil, Kuftinec, Gabriela N., Deshpande, Amar R., Yadav, Dhiraj, Saul, Melissa, Mays, Melanie, Anderson, Gulsum, Wood, Kelley, Mathews, Laura, Fox, Charlie, Kolb, Jennifer M., Wani, Sachin, Pawa, Swati, Pawa, Rishi, Canakis, Andrew, Huang, Christopher, Jamil, Laith H., Aneese, Andrew M., Gjeorgjievski, V. Mihajlo, Imam, Zaid, Odish, Fadi, Edhi, Ahmed I., Orosey, Molly, Tiwari, Abhinav, Patwardhan, Soumil, Glamour, Benita K., Smith, Zachary L., Hosmer, Amy E., Furey, Nancy, Chak, Amitabh, Hanley, Katherine A., Wood, Jordan, Keswani, Rajesh N., Patel, Harsh K., Shah, Janak N., Agarunov, Emil, Brown, Nicholas G., Patel, Anish A., Sethi, Amrita, Fogel, Evan L., McNulty, Gail, Haseeb, Abdul, Trieu, Judy A., Dixon, Rebekah E., Yang, Jeong Yun, DiMaio, Christopher J., Mendelsohn, Robin B., Calo, Delia, Aroniadis, Olga C., LaComb, Joseph F., Cruz, Lilian, Reykhart, Olga, Sauer, Bryan G., Diakova, Galina, Dang, Duyen T., Piraka, Cyrus R., Shah, Eric D., Caisse, Molly, Zbib, Natalia H., Damianos, John A., Pohl, Heiko, Mitchell, Stephanie, Bronze, Michael S., Condon, Ashwinee, Lenhart, Adrienne, Muthusamy, Raman, Dua, Kulwinder S., Kanagala, Vikram S., Esteban, James, Kamal, Ayesha, Canto, Marcia I., Singh, Vikesh K., Pinto-Sanchez, Maria Ines, Hutchinson, Joy M., Kwon, Richard S., Korsnes, Sheryl J., Waljee, Akbar K., Tang, Weijing, Zhang, Yueyang, Zhu, Ji, Singh, Harminder, Solati, Zahra, Hajidiacos, Nick, Elmunzer, B. Joseph, Wolf, Bethany J., Scheiman, James M., Tierney, William M., and Taylor, Jason R.

Published
2021
Full Text
View/download PDF

29. Recruitment and Retention Strategies for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium

Author

Yazici, Cemal, Dyer, Anne-Marie, Conwell, Darwin L., Afghani, Elham, Andersen, Dana K., Basina, Marina, Bellin, Melena D., Boone, Leslie R., Casu, Anna, Easler, Jeffrey J., Greenbaum, Carla J., Hart, Phil A., Jeon, Christie Y., Lee, Peter J., Meier, Shelby, Papachristou, Georgios I., Raja-Khan, Nazia T., Saeed, Zeb I., Serrano, Jose, Yadav, Dhiraj, and Fogel, Evan L.

Published
2022
Full Text
View/download PDF

30. Design and Rationale for the Use of Magnetic Resonance Imaging Biomarkers to Predict Diabetes After Acute Pancreatitis in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium

Author

Tirkes, Temel, Chinchilli, Vernon M., Bagci, Ulas, Parker, Jason G., Zhao, Xuandong, Dasyam, Anil K., Feranec, Nicholas, Grajo, Joseph R., Shah, Zarine K., Poullos, Peter D., Spilseth, Benjamin, Zaheer, Atif, Xie, Karen L., Wachsman, Ashley M., Campbell-Thompson, Martha, Conwell, Darwin L., Fogel, Evan L., Forsmark, Christopher E., Hart, Phil A., Pandol, Stephen J., Park, Walter G., Pratley, Richard E., Yazici, Cemal, Laughlin, Maren R., Andersen, Dana K., Serrano, Jose, Bellin, Melena D., and Yadav, Dhiraj

Published
2022
Full Text
View/download PDF

31. Rectal indometacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients: a double-blind, randomised controlled trial

Author

Fogel, Evan L, Lehman, Glen A, Tarnasky, Paul, Cote, Gregory A, Schmidt, Suzette E, Waljee, Akbar K, Higgins, Peter D R, Watkins, James L, Sherman, Stuart, Kwon, Richard S Y, Elta, Grace H, Easler, Jeffrey J, Pleskow, Douglas K, Scheiman, James M, El Hajj, Ihab I, Guda, Nalini M, Gromski, Mark A, McHenry, Lee, Jr, Arol, Seena, Korsnes, Sheryl, Suarez, Alejandro L, Spitzer, Rebecca, Miller, Marilyn, Hofbauer, Maria, and Elmunzer, B Joseph

Published
2020
Full Text
View/download PDF

34. Diagnostic and Prognostic Biomarkers of Chronic Pancreatitis: A Conceptual Framework Based on the PRoBE Design

Author

Andersen, Dana, Bellin, Melena, Chari, Suresh T., Cruz-Monserrate, Zobeida, Fisher, William E., Fogel, Evan L., Forsmark, Christopher E., Hart, Phil A., Lesinski, Gregory B., Park, Walter G., Rinaudo, Jo Ann, Saloman, Jami L., Serrano, Jose, Tirkes, Temel, Topazian, Mark D., van Den Eeden, Stephen, Vege, Santhi Swaroop, Whitcomb, David C., Yadav, Dhiraj, Conwell, Darwin L., Pandol, Stephen J., Steen, Hanno, Feng, Ziding, and Li, Liang

Published
2024
Full Text
View/download PDF

36. Distinct Serum Immune Profiles Define the Spectrum of Acute and Chronic Pancreatitis From the Multicenter Prospective Evaluation of Chronic Pancreatitis for Epidemiologic and Translational Studies (PROCEED) Study

Author

Lee, Bomi, primary, Jones, Elaina K., additional, Manohar, Murli, additional, Li, Liang, additional, Yadav, Dhiraj, additional, Conwell, Darwin L., additional, Hart, Phil A., additional, Vege, Santhi Swaroop, additional, Fogel, Evan L., additional, Serrano, Jose, additional, Andersen, Dana, additional, Bellin, Melena D., additional, Topazian, Mark D., additional, Van Den Eeden, Stephen K., additional, Pandol, Stephen J., additional, Forsmark, Chris E., additional, Fisher, William E., additional, Park, Walter G., additional, Husain, Sohail Z., additional, Habtezion, Aida, additional, Topazian, Mark, additional, and Forsmark, Chris, additional

Published
2023
Full Text
View/download PDF

38. Contributors

Author

Adler, Douglas G., primary, Ahlawat, Sushil K., additional, Ahmad, Jawad, additional, Al-Kawas, Firas H., additional, Anderson, Michelle A., additional, de Almeida Artifon, Everson Luiz, additional, de Andrade Lima Cabral, João Guilherme Guerra, additional, Baillie, John, additional, Banerjee, Rupa, additional, Baron, Todd H., additional, Basar, Omer, additional, Benias, Petros C., additional, Boškoski, Ivo, additional, Bourke, Michael J., additional, Brauer, Brian C., additional, Brugge, William R., additional, Buscaglia, Jonathan M., additional, Carr-Locke, David L., additional, Chahal, Prabhleen, additional, Chandran, Sujievvan, additional, Chen, Yen-I, additional, Choi, Anthony J., additional, Cohen, Jonah, additional, Costamagna, Guido, additional, Coté, Gregory A., additional, Cotton, Peter, additional, Das, Koushik K., additional, Devière, Jacques, additional, Edmundowicz, Steven A., additional, El Hajj, Ihab I., additional, Faigel, Douglas O., additional, Familiari, Pietro, additional, Fockens, Paul, additional, Fogel, Evan L., additional, Fox, Victor L., additional, Freeman, Martin L., additional, Gan, S. Ian, additional, Gelrud, Andres, additional, Ginsberg, Gregory G., additional, Gluck, Michael, additional, Goh, Khean-Lee, additional, Hawes, Robert H., additional, Higa, Jennifer T., additional, Holmes, Jordan D., additional, Irani, Shayan, additional, Itoi, Takao, additional, Jamidar, Priya A., additional, Kahaleh, Michel, additional, Kalloo, Anthony N., additional, Khashab, Mouen A., additional, Kochman, Michael L., additional, Kodama, Tadashi, additional, Korman, Andrew, additional, Kortan, Paul, additional, Koshitani, Tatsuya, additional, Kozarek, Richard A., additional, Larsen, Michael, additional, Lau, James Y.W., additional, Law, Ryan, additional, Lehman, Glen, additional, Leung, Joseph W., additional, Ligresti, Dario, additional, Lin, Eugene, additional, Lo, Simon K., additional, Ma, Michael X., additional, Maple, John T., additional, Mariani, Alberto, additional, May, Gary, additional, McHenry, Lee, additional, Mizrahi, Meir, additional, Mounzer, Rawad, additional, Muniraj, Thiruvengadam, additional, Neuhaus, Horst, additional, Norton, Ian D., additional, Perez-Miranda, Manuel, additional, Petersen, Bret T., additional, Pleskow, Douglas, additional, Purnak, Tugrul, additional, Rao, G. Venkat, additional, Razzak, Anthony, additional, Reddy, D. Nageshwar, additional, Ross, Andrew S., additional, Sarkisian, Alexander M., additional, Schueler, Beth, additional, Seo, Dong Wan, additional, Shah, Raj J., additional, Sharaiha, Reem Z., additional, Sherman, Stuart, additional, Shim, Chan Sup, additional, Singh, Ajaypal, additional, Slivka, Adam, additional, Solomon, Sanjeev, additional, Song, Tae Jun, additional, Srinivasan, Indu, additional, Sung, Joseph J.Y., additional, Tarantino, Ilaria, additional, Tarnasky, Paul R., additional, Testoni, Pier Alberto, additional, Tobin, Catherine D., additional, Topazian, Mark, additional, Wani, Sachin, additional, Wong, John C.T., additional, and Yen, Andrew W., additional

Published
2019
Full Text
View/download PDF

40. Contributors

Author

Achord, James L., primary, Alfa, Michelle J., additional, Al-Haddad, Mohammad, additional, Anderloni, Andrea, additional, Anderson, Joseph C., additional, Baiges, Anna, additional, Baillie, John, additional, Barkun, Alan N., additional, Baron, Todd H., additional, Basar, Omer, additional, Benson, Mark, additional, Silva, Lyz Bezerra, additional, Bezobchuk, Stas, additional, Binmoeller, Kenneth F., additional, Blankstein, Sarah, additional, Blero, Daniel, additional, Bourke, Michael J., additional, Brugge, William R., additional, Bruno, Marco J., additional, Buchner, Anna M., additional, Cárdenas, Andrés, additional, Carr-Locke, David, additional, Chang, Kenneth, additional, Chawla, Saurabh, additional, Clarke, John O., additional, Cohen, Jonathan, additional, Copland, Andrew P., additional, Costamagna, Guido, additional, Cotton, Peter B., additional, Desai, Amit P., additional, Devière, Jacques, additional, DiMaio, Christopher J., additional, Draganov, Peter, additional, Dumortier, Jérôme, additional, Easler, Jeffrey J., additional, Falk, Gary W., additional, Farraye, Francis A., additional, Feld, Andrew, additional, Feld, Kayla, additional, Fockens, Paul, additional, Fogel, Evan L., additional, Fortinsky, Kyle J., additional, Freeman, Martin L., additional, Carlos, Juan, additional, Gerdes, Hans, additional, Gibson, Joanna A., additional, Ginsberg, Gregory G., additional, Giovannini, Marc, additional, Gralnek, Ian M., additional, Gress, Frank G., additional, Hawes, Robert H., additional, Hernández-Gea, Virginia, additional, Hirano, Ikuo, additional, Hochberger, Juergen, additional, Howell, Douglas A., additional, Hur, Chin, additional, Hwang, Joo Ha, additional, Ibáñez, Maite Betés, additional, Itoi, Takao, additional, Iyer, Prasad G., additional, Johnson, David A., additional, Jonnalagadda, Sreeni, additional, Kahi, Charles J., additional, Kaltenbach, Tonya, additional, Kia, Leila, additional, Kimmey, Michael B., additional, Klein, Amir, additional, Kochman, Michael L., additional, Kohli, Divyanshoo R., additional, Korman, Andrew, additional, Kwong, Wilson T., additional, Law, Ryan, additional, Leiman, David A., additional, Lennon, Anne Marie, additional, Levy, Michael, additional, Lichtenstein, David, additional, Lichtenstein, Gary R., additional, Likhitsup, Alisa, additional, Limdi, Jimmy K., additional, Lollo, Gianluca, additional, Maluf-Filho, Fauze, additional, Maranki, Jennifer, additional, McCallum, Richard W., additional, McClave, Stephen A., additional, Mergener, Klaus, additional, Metz, David C., additional, Meves, Volker, additional, Morris, Marcia L., additional, Mullady, Daniel K., additional, Muñoz-Navas, Miguel, additional, Muthusamy, V. Raman, additional, Nabi, Zaheer, additional, Nett, Andrew, additional, Nguyen, Nam Q., additional, Nickl, Nicholas, additional, Nonaka, Satoru, additional, Oda, Ichiro, additional, Odze, Robert D., additional, Oldfield, Edward C., additional, Parekh, Parth J., additional, Pfau, Patrick R., additional, Pioche, Mathieu, additional, Pohl, Heiko, additional, Ponchon, Thierry, additional, Ponec, Robert J., additional, Rajala, Michael W., additional, Reddy, Nageshwar, additional, Repici, Alessandro, additional, Rivory, Jérôme, additional, Ryou, Marvin, additional, Saito, Yutaka, additional, Samarasena, Jason B., additional, Savides, Thomas J., additional, Schoeman, Mark, additional, Schulman, Allison R., additional, Sethi, Amrita, additional, Shah, Pari M., additional, Sherman, Stuart, additional, Siddiqui, Uzma D., additional, Singh, Vikesh K., additional, Soetikno, Roy, additional, Stavropoulos, Stavros N., additional, Stevens, Tyler, additional, Surawicz, Christina, additional, Tanner, Barry, additional, Tarnasky, Paul, additional, Thompson, Christopher C., additional, Topazian, Mark, additional, Triadafilopoulos, George, additional, van Halsema, Emo E., additional, van Hooft, Jeanin E., additional, Vargo, John Joseph, additional, Visrodia, Kavel, additional, Wadhwa, Vaibhav, additional, Wall, Kristian, additional, Walsh, Catharine M., additional, Wang, Andrew Y., additional, Wang, Kenneth K., additional, Wani, Sachin, additional, Wilcox, C. Mel, additional, Willingham, Field F., additional, Yachimski, Patrick S., additional, and Zorron, Ricardo, additional

Published
2019
Full Text
View/download PDF

42. Evaluation of Pharmacologic Prevention of Pancreatitis After Endoscopic Retrograde Cholangiopancreatography: A Systematic Review

Author

Kubiliun, Nisa M., Adams, Megan A., Akshintala, Venkata S., Conte, Marisa L., Cote, Gregory A., Cotton, Peter B., Dumonceau, Jean-Marc, Elta, Grace H., Fogel, Evan L., Freeman, Martin L., Lehman, Glen A., Naveed, Mariam, Romagnuolo, Joseph, Scheiman, James M., Sherman, Stuart, Singh, Vikesh K., and Elmunzer, B. Joseph

Published
2015
Full Text
View/download PDF

43. Development of a Clinical Prediction Model for Diabetes in Chronic Pancreatitis: The PREDICT3c Study

Author

Jeon, Christie, primary, Hart, Phil A., primary, Li, Liang, primary, Yang, Yunlong, primary, Chang, Eleanor, primary, Bellin, Melena D., primary, Fisher, William E., primary, Fogel, Evan L., primary, Forsmark, Christopher E., primary, Park, Walter G., primary, K. Van Den Eeden, Stephen, primary, Vege, Santhi Swaroop, primary, Serrano, José, primary, Whitcomb, David C., primary, Andersen, Dana K., primary, Conwell, Darwin L., primary, Yadav, Dhiraj, primary, and Goodarzi, Mark O, primary

Published
2022
Full Text
View/download PDF

44. Association of Chronic Pancreatitis Pain Features With Physical, Mental, and Social Health

Author

Yadav, Dhiraj, primary, Askew, Robert L., additional, Palermo, Tonya, additional, Li, Liang, additional, Andersen, Dana K., additional, Chen, Minxing, additional, Fisher, William E., additional, Fogel, Evan L., additional, Forsmark, Christopher E., additional, Hart, Phil A., additional, Othman, Mohamed O., additional, Pandol, Stephen J., additional, Park, Walter G., additional, Topazian, Mark D., additional, Van Den Eeden, Stephen K., additional, Vege, Santhi Swaroop, additional, Yang, Yunlong, additional, Serrano, Jose, additional, and Conwell, Darwin L., additional

Published
2022
Full Text
View/download PDF

47. Rationale and Design for the Diabetes RElated to Acute Pancreatitis and Its Mechanisms Study: A Prospective Cohort Study From the Type 1 Diabetes in Acute Pancreatitis Consortium

Author

Hart, Phil A, Papachristou, Georgios I, Park, Walter G, Dyer, Anne-Marie, Chinchilli, Vernon M, Afghani, Elham, Akshintala, Venkata S, Andersen, Dana K, Buxbaum, James L, Conwell, Darwin L, Dungan, Kathleen M, Easler, Jeffrey J, Fogel, Evan L, Greenbaum, Carla J, Kalyani, Rita R, Korc, Murray, Kozarek, Richard, Laughlin, Maren R, Lee, Peter J, Maranki, Jennifer L, Pandol, Stephen J, Phillips, Anna Evans, Serrano, Jose, Singh, Vikesh K, Speake, Cate, Tirkes, Temel, Toledo, Frederico GS, Trikudanathan, Guru, Vege, Santhi Swaroop, Wang, Ming, Yazici, Cemal, Zaheer, Atif, Forsmark, Christopher E, Bellin, Melena D, Yadav, Dhiraj, and Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC)

Subjects
insulin, acute pancreatitis, Clinical Sciences, data coordinating center, FSIGTT, chronic pancreatitis, oral glucose tolerance testing, T1DAPC, Diabetes Mellitus, DM, OGTT, Humans, Diabetes RElated to Acute pancreatitis and its Mechanisms, Prospective Studies, Type 1 Diabetes in Acute Pancreatitis Consortium, DCC, frequently sampled intravenous glucose tolerance testing, MMTT, type 3c diabetes, Gastroenterology & Hepatology, Incidence, Prevention, Diabetes, DREAM, pancreatogenic diabetes, beta cell, Pancreatitis, CP, mixed meal tolerance testing, Acute Disease, diabetes mellitus, epidemiology, AP, autoantibody, Type 1
Abstract

Acute pancreatitis (AP) is a disease characterized by an acute inflammatory phase followed by a convalescent phase. Diabetes mellitus (DM) was historically felt to be a transient phenomenon related to acute inflammation; however, it is increasingly recognized as an important late and chronic complication. There are several challenges that have prevented precisely determining the incidence rate of DM after AP and understanding the underlying mechanisms. The DREAM (Diabetes RElated to Acute Pancreatitis and its Mechanisms) Study is a prospective cohort study designed to address these and other knowledge gaps to provide the evidence needed to screen for, prevent, and treat DM after AP. In the following article, we summarize literature regarding the epidemiology of DM after AP and provide the rationale and an overview of the DREAM study.

Published
2022

48. Design and Rationale for the Use of Magnetic Resonance Imaging Biomarkers to Predict Diabetes Following Acute Pancreatitis in the Diabetes RElated to Acute Pancreatitis and Its Mechanisms (DREAM) Study: From the Type 1 Diabetes in Acute Pancreatitis Consortium (T1DAPC)

Author

Tirkes, Temel, Chinchilli, Vernon M., Bagci, Ulas, Parker, Jason G., Zhao, Xuandong, Dasyam, Anil K., Feranec, Nicholas, Grajo, Joseph R., Shah, Zarine K., Poullos, Peter D., Spilseth, Benjamin, Zaheer, Atif, Xie, Karen L., Wachsman, Ashley M., Campbell-Thompson, Martha, Conwell, Darwin L., Fogel, Evan L., Forsmark, Christopher E., Hart, Phil A., Pandol, Stephen J., Park, Walter G., Pratley, Richard E., Yazici, Cemal, Laughlin, Maren R., Andersen, Dana K., Serrano, Jose, Bellin, Melena D., and Yadav, Dhiraj

Subjects
Diabetes Mellitus, Type 1, Pancreatitis, Artificial Intelligence, Acute Disease, Humans, Magnetic Resonance Imaging, Article, Biomarkers
Abstract

This core component of the Diabetes RElated to Acute pancreatitis and its Mechanisms (DREAM) study will examine the hypothesis that advanced magnetic resonance imaging (MRI) techniques can reflect underlying pathophysiologic changes and provide imaging biomarkers that predict diabetes mellitus (DM) after acute pancreatitis (AP). A subset of participants in the DREAM study will enroll and undergo serial MRI examinations using a specific research protocol. The aim of the study is to differentiate at-risk individuals from those who remain euglycemic by identifying parenchymal features after AP. Performing longitudinal MRI will enable us to observe and understand the natural history of post-AP DM. We will compare MRI parameters obtained by interrogating tissue properties in euglycemic, prediabetic, and incident diabetes subjects and correlate them with metabolic, genetic, and immunological phenotypes. Differentiating imaging parameters will be combined to develop a quantitative composite risk score. This composite risk score will potentially have the ability to monitor the risk of DM in clinical practice or trials. We will use artificial intelligence, specifically deep learning, algorithms to optimize the predictive ability of MRI. In addition to the research MRI, the DREAM study will also correlate clinical computed tomography and MRI scans with DM development.

Published
2022

49. Clinical Trials in Pancreatitis: Opportunities and Challenges in the Design and Conduct of Patient-Focused Clinical Trials in Recurrent Acute and Chronic Pancreatitis

Author

Hart, Phil A., primary, Andersen, Dana K., additional, Lyons, Erica, additional, Cote, Gregory A., additional, Cruz-Monserrate, Zobeida, additional, Dworkin, Robert H., additional, Elmunzer, B. Joseph, additional, Fogel, Evan L., additional, Forsmark, Christopher E., additional, Gilron, Ian, additional, Golden, Megan, additional, Gozu, Aysegul, additional, McNair, Lindsay, additional, Pandol, Stephen J., additional, Perito, Emily R., additional, Phillips, Anna Evans, additional, Rabbitts, Jennifer A., additional, Whitcomb, David C., additional, Windsor, John A., additional, Yadav, Dhiraj, additional, and Palermo, Tonya M., additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results